What is Illumina's payments for repurchase of common stock?

Illumina (ILMN) reported payments for repurchase of common stock of $242M in Q1 2026.

How has Illumina's payments for repurchase of common stock changed year-over-year?

Illumina's payments for repurchase of common stock increased by 21.0% year-over-year, from $200M to $242M.

Illumina ILMN Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

RevvityRVTY

——

Thermo Fisher ScientificTMO

——

Bio-Rad LaboratoriesBIO

——

Fulgent Genetics, Inc.FLGT

——

Other financials

Income statement

See full

Revenue$1.2B+9.4%

Gross profit$770.0M+10.8%

Operating income$245.0M+14.5%

Net income$207.0M-11.9%

EPS (diluted)$1.35-9.4%

Balance sheet

See full

Cash & equivalents$1.0B+11.3%

Total debt$1.9B-7.3%

Total equity$2.8B+25.7%

Total assets$6.7B+9.2%

Cash flow

See full

Operating cash flow$201.0M-14.1%

CapEx$39.0M+30.0%

Free cash flow$162.0M-20.6%

Valuation

See full

Market cap$29.2B+69.7%

Enterprise value$30.1B+63.8%

P/E35.4×+21.7×

P/S6.5×+2.5×

Profitability

See full

Gross margin66.4%-0.2pp

Operating margin19.6%—

Net margin18.4%-11.0pp

FCF margin20.7%-3.3pp

Returns & leverage

See full

Return on equity32.4%-35.7pp

Debt / equity0.7×-0.2×

Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Illumina's payments for repurchase of common stock?: Illumina (ILMN) reported payments for repurchase of common stock of $242M in Q1 2026.
How has Illumina's payments for repurchase of common stock changed year-over-year?: Illumina's payments for repurchase of common stock increased by 21.0% year-over-year, from $200M to $242M.